8-K
filed June 15, 2023, 7:59 PM ET
ticker XFOR
CIK 0001501697
other
confidence high
sentiment neutral
materiality 0.10
X4 Pharmaceuticals stockholders elect three directors and approve all proposals at 2023 annual meeting
X4 Pharmaceuticals, Inc
- Elected Gary J. Bridger, Francoise de Craecker, and Murray W. Stewart as directors for three-year terms.
- Ratified PricewaterhouseCoopers LLP as independent auditor for FY2023 with 94.3M votes for.
- Advisory vote on named executive officer compensation approved with 59.3M for vs 8.0M against.
- Stockholders preferred a one-year frequency for future say-on-pay votes; board adopted annual votes.
- Approved Amended and Restated 2017 Employee Stock Purchase Plan with 66.7M votes for.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
X4 Pharmaceuticals, Inc shareholders approved Advisory Vote on the Compensation of the Named Executive Officers at the 2023-06-13 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-06-13
Exact text from the filing
The votes cast were as follows: For Against Abstain Broker Non-Votes 59,263,769 7,988,869 175,031 26,939,489
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
X4 Pharmaceuticals, Inc shareholders approved Ratification of the Selection of Independent Registered Public Accounting Firm at the 2023-06-13 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-13
Exact text from the filing
The votes cast were as follows: For Against Abstain Broker Non-Votes 94,283,872 71,919 11,367 —
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
X4 Pharmaceuticals, Inc shareholders approved Approval of the Company's Amended and Restated 2017 Employee Stock Purchase Plan at the 2023-06-13 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-06-13
Exact text from the filing
The votes cast were as follows: For Against Abstain Broker Non-Votes 66,701,613 641,702 84,354 26,939,489
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
X4 Pharmaceuticals, Inc shareholders approved Election of Directors at the 2023-06-13 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-13
Exact text from the filing
The votes cast were as follows: Nominees For Withheld Broker Non-Votes Gary J. Bridger, Ph.D. 60,120,050 7,307,619 26,939,489 Francoise de Craecker 60,283,484 7,144,185 26,939,489 Murray W. Stewart, M.D. 60,138,639 7,289,030 26,939,489
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
X4 Pharmaceuticals, Inc shareholders approved Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation at the 2023-06-13 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2023-06-13
Exact text from the filing
The votes cast were as follows: 1 Year 2 Years 3 Years Abstain 60,811,809 6,157,200 396,956 61,704
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.